We develop and test the model using data from two scenarios: (i) the progression towards insulin resistance due to weight gain, with data for fasting glucose and insulin levels, as well as intracellular insulin signaling in adipocytes (Fig. 1c), and (ii) a weight loss scenario, due to decreased energy intake alone, and due to additional drug usage (Fig. 1d). Here, INS is linked to Insulin resistance.